Next Gen's Vision: To be a leading provider of venture capital, management expertise, education and a facilitator for this explosive new industry
Next Gen plans to consolidate certain sectors of this fragmented industry
To that end:
-The Company's business model continues to generate new business plans and project submittals 24/7
-Management is currently reviewing over 45 business plans and proposals
-Next Gen's Management is currently finalizing its Industry Advisory Board
Vancouver, British Columbia / ACCESSWIRE / March 13, 2014 / Next Gen Metals Inc. ("Next Gen", "The Company") (CSE: N, OTC Pink: NXTTF, FSE: M5BN) is pleased to announce that Mr. Michael Hektoen has been added to Next Gen's Medical Marijuana and Industrial Hemp business development team. With years of business development experience, Michael will help create long-term shareholder value for the company by providing guidance and expertise in areas directly related to Next Gen's business model (see the company's press release dated February 26, 2014).
Mr. Barr, Presdient and CEO stated that "A growing proportion of the medical community believe that Medical Marijuana and, more specifically cannabinoids, have the potential to help patients who are suffering from a variety of ailments and illnesses. In addition, Industrial Hemp is an emerging industry in Canada and hemp is one of the strongest natural fibers known to man. Hemp has a wide range of applications including medicine. Both sectors show the potential for exponential growth."
Mr. Barr further stated that "On behalf of the board of directors and management of Next Gen, I am pleased to have Mr. Hektoen join the Next Gen Team. We are confident his diversified skills set and business experience will add to our existing and growing team of professionals dedicated to this explosive new industry."
About Michael Hektoen
Mr. Hektoen is dual citizen of the United States and Canada and was the Founder, President and CEO of a fully listed NASDAQ traded company in the entertainment-media industry. He has advised privately owned and publicly traded companies in areas such as due diligence, joint ventures, business development, marketing, social networking, branding and corporate finance.
Mr. Hektoen was retained by the Canadian Aboriginal Housing Management Association to provide guidance for the first World Indigenous Housing Conference held in Vancouver, BC Canada in 2012. He also organized the attendance of leading Tribal, Government, and Business leaders from the US and Canada for the Global Arc Boston Conference attended by Global Pension, Endowment and Hedge Fund leaders. The subject of the session was 'Meeting the Investment Needs of the Native American Nations'.
He is celebrating his 38th year in the music-entertainment industry as a music producer, artist manager and Owner - CEO of the world famous NYC based Media Sound Studios where Barbra Streisand, Guns and Roses, Luther Vandross, Ray Charles, Rolling Stones, Aretha Franklin, Madonna, Frank Sinatra, Aerosmith, Tina Turner, Whitney Houston, Billy Joel, John Hammond Sr. and Mariah Carey among others recorded and was the co-owner of TWM Management who provided career management services to acts such as Kool & The Gang and The Manhattans. His efforts helped artists generate over 100 gold and platinum records.
About Next Gen
Next Gen is a diversified Canadian public company which is focused on investing in the Medical Marijuana and Industrial Hemp business sector. Recent regulatory/legal changes in North America have provided an opportunity for the company to enter into this emerging multi-billion dollar industry. Next Gen's vision is to be a leading provider of venture capital, management expertise, education and a facilitator for this explosive new industry.
Next Gen plans to provide financing for both private/publicly listed Medical Marijuana and Industrial Hemp companies in exchange for an equitable interest in their business and/or a royalty on sales. Next Gen also intends on incubating companies that are technically savvy but require professional assistance in fundraising, complex negotiations, capital markets, public company administration and IPO's.
Management is currently reviewing and soliciting new business proposals in various segments of the industry including: health, food, agri-business, legal grow-ops, research & technology, client generation, education, public awareness, specialty clinics and ancillary business opportunities. For further information, visit our website at www.nextgenmetalsinc.com. On another matter, the Company will issue a total of 100,000 stock options to two consultants at $0.21 per share.
For further information contact Investor Relations:
Tel: +1 604 685 1870 Toll Free 1.800.667.1870 Fax: +1 604 685 8045
Email: firstname.lastname@example.org or visit http://www.nextgenmetalsinc.com
650-555 West 12th Avenue, City Square,
West Tower, Vancouver, B.C., Canada, V5Z 3X7
On behalf of the Board of Directors
President & CEO
FORWARD LOOKING INFORMATION
This News Release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements.
Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents which can be found under the Company's profile on www.sedar.com.
This News Release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
The CSE has neither reviewed or approved the contents of this News Release.